Garry E Menzel - Net Worth and Insider Trading

Over the past 18 months, Garry E Menzel made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net purchase of 3,140,000 shares made by Biotech Growth N V , a net purchase of 1,000,000 shares made by Ali Behbahani , and a net purchase of 935,850 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 0 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,000 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 5,132,213 shares were bought by its insiders, resulting in a net purchase of 5,107,213 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made 4 insider transaction in TCR2 Therapeutics Inc (TCRR) with a net sale of 82,187. Other recent insider transactions involving TCR2 Therapeutics Inc (TCRR) include a net purchase of 468,513 shares made by Kevin C Tang , a net sale of 32,841 shares made by Alfonso Quintas Cardama , and a net sale of 20,524 shares made by Angela Justice .

In summary, during the past 3 months, insiders sold 0 shares of TCR2 Therapeutics Inc (TCRR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 287,401 shares of TCR2 Therapeutics Inc (TCRR) were sold and 468,513 shares were bought by its insiders, resulting in a net purchase of 181,112 shares.

TCR2 Therapeutics Inc (TCRR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made no insider transaction in DaVita Inc (DVA). Other recent insider transactions involving DaVita Inc (DVA) include a net sale of 37,020 shares made by Kathleen Alyce Waters , a net sale of 91,916 shares made by Javier Rodriguez , and a net sale of 31,909 shares made by James O Hearty .

In summary, during the past 3 months, insiders sold 120,803 shares of DaVita Inc (DVA) in total and bought 0 shares, with a net sale of 120,803 shares. During the past 18 months, 202,174 shares of DaVita Inc (DVA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 202,174 shares.

DaVita Inc (DVA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 14,580 shares made by Joseph P Hagan , a net sale of 5,468 shares made by Christopher Ray Aker , and a net sale of 5,468 shares made by Crispina Calsada .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 25,516 shares of Regulus Therapeutics Inc (RGLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,516 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 149,116 shares made by Barry Ticho , a net sale of 9,423 shares made by Jonathan Allan , and a net sale of 3,600,000 shares made by Skorpios Trust .

In summary, during the past 3 months, insiders sold 3,650,973 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 3,650,973 shares. During the past 18 months, 3,777,921 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,777,921 shares.

Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Garry E Menzel made 1 insider transaction in Adaptimmune Therapeutics PLC (ADAP) with a net sale of 47,702. Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.